Latest Articles
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com Nigeria
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com Nigeria
Published: Jan. 24, 2026, 5:45 a.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress By Investing.com - Investing.com India
Acrivon to present ACR-368 endometrial cancer data at ESGO congress By Investing.com Investing.com India
Published: Jan. 24, 2026, 4:02 a.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com Canada
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com Canada
Published: Jan. 23, 2026, 10:24 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com Australia
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com Australia
Published: Jan. 23, 2026, 3:48 p.m.
Ibuprofen may decrease cancer risk - Female First
Ibuprofen may decrease cancer risk Female First
Published: Jan. 23, 2026, 3:16 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com
Published: Jan. 23, 2026, 2:07 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com UK
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com UK
Published: Jan. 23, 2026, 1:18 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology
Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com
Published: Jan. 22, 2026, 4:02 p.m.
Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer - CancerNetwork
Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer CancerNetwork
Published: Jan. 21, 2026, 4:57 p.m.
Link copied to clipboard!